Nimotuzumab and chemotherapy
BT-NSCLC-T-0902
Phase 1 small_molecule terminated
Quick answer
Nimotuzumab and chemotherapy for Non-small Cell Lung Cancer is a Phase 1 program (small_molecule) at Biotech Pharmaceutical Co., with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Biotech Pharmaceutical Co.,
- Indication
- Non-small Cell Lung Cancer
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- terminated